Adagene Inc. (ADAG)
3.27
0.00 (0.00%)
Upcoming Events
Latest Headlines
Third Arc Bio picks lead candidate in amended Adagene collaboration
September 10, 2026 8:03 AM - StreetInsider
Form 6-K Adagene Inc. For: Sep 10
September 10, 2026 8:00 AM - SEC Filing
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
September 10, 2026 8:00 AM - StreetInsider
Chardan Starts Adagene Inc (ADAG) at Buy
September 10, 2026 6:33 AM - StreetInsider
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
September 9, 2026 8:00 AM - StreetInsider
Form 144/A Adagene Inc. Filed by: GU CHUNFANG
August 20, 2026 6:12 PM - SEC Filing
Adagene to Participate in Three Upcoming Investor Conferences
August 20, 2026 8:00 AM - StreetInsider
Form 144 Adagene Inc. Filed by: GU CHUNFANG
August 19, 2026 10:22 AM - SEC Filing
Form 4 Adagene Inc. For: Aug 14 Filed by: DO CUONG V
August 18, 2026 6:11 PM - SEC Filing
Form 4 Adagene Inc. For: Aug 13 Filed by: Zhu Li
August 17, 2026 8:32 PM - SEC Filing
Form 4 Adagene Inc. For: Aug 13 Filed by: Cheung Andy Yiu Leung
August 17, 2026 8:31 PM - SEC Filing
Form 4 Adagene Inc. For: Aug 13 Filed by: DO CUONG V
August 17, 2026 8:30 PM - SEC Filing
Form SCHEDULE 13G/A Adagene Inc. Filed by: WuXi PharmaTech Healthcare Fund I L.P.
August 14, 2026 4:58 PM - SEC Filing
Form 4 Adagene Inc. For: Aug 13 Filed by: Grawunder Ulf
August 14, 2026 11:20 AM - SEC Filing
Form 6-K Adagene Inc. For: Jun 30
August 12, 2026 7:31 AM - SEC Filing
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
August 12, 2026 7:30 AM - StreetInsider
Form 4 Adagene Inc. For: Aug 06 Filed by: Luo Peter
August 6, 2026 6:16 PM - SEC Filing
Guggenheim Reiterates Buy Rating on Adagene Inc (ADAG)
July 14, 2026 6:44 AM - StreetInsider
Form 6-K Adagene Inc. For: Jul 06
July 6, 2026 8:01 AM - SEC Filing
Full Article List
